Drug Resistance Updates
Volume 12, Issue 4 , Pages 127-136 , August 2009

Adhesion-mediated apoptosis resistance in cancer

Received 1 June 2009 ,Revised 14 June 2009 ,Accepted 3 August 2009.

References 

  1. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007;26:1324–1337
  2. Almeida EA, Ilic D, Han Q, Hauck CR, Jin F, Kawakatsu H, et al. Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J. Cell Biol. 2000;149:741–754
  3. Amaravadi RK, Thompson CB. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 2007;13:7271–7279
  4. Amin AR, Ichigotani Y, Oo ML, Biswas MH, Yuan H, Huang P, et al. The PLC-PKC cascade is required for IL-1beta-dependent Erk and Akt activation: their role in proliferation. Int. J. Oncol. 2003;23:1727–1731
  5. Angst BD, Marcozzi C, Magee AI. The cadherin superfamily: diversity in form and function. J. Cell Sci. 2001;114:629–641
  6. Aoudjit F, Vuori K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene. 2001;20:4995–5004
  7. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG, et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat. Cell Biol. 2002;4:632–638
  8. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 2009;5:1–13
  9. Baehrecke EH. Autophagy: dual roles in life and death?. Nat. Rev. Mol. Cell Biol. 2005;6:505–510
  10. Bansal N, Banerjee D. Tumor initiating cells. Curr. Pharm. Biotechnol. 2009;10:192–196
  11. Barberis L, Wary KK, Fiucci G, Liu F, Hirsch E, Brancaccio M, et al. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J. Biol. Chem. 2000;275:36532–36540
  12. Barnhart BC, Lee JC, Alappat EC, Peter ME. The death effector domain protein family. Oncogene. 2003;22:8634–8644
  13. Beavon IR. The E-cadherin–catenin complex in tumour metastasis: structure, function and regulation. Eur. J. Cancer. 2000;36:1607–1620
  14. Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA, et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. U.S.A. 2008;105:16677–16682
  15. Berezovskaya O, Schimmer AD, Glinskii AB, Pinilla C, Hoffman RM, Reed JC, et al. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 2005;65:2378–2386
  16. Bissell MJ, Radisky D. Putting tumours in context. Nat. Rev. Cancer. 2001;1:46–54
  17. Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J, Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J. Cell. Biochem. 2000;79:355–369
  18. Calaora V, Rogister B, Bismuth K, Murray K, Brandt H, Leprince P, et al. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J. Neurosci. 2001;21:4740–4751
  19. Chae B, Yang KM, Kim TI, Kim WH. Adherens junction-dependent PI3K/Akt activation induces resistance to genotoxin-induced cell death in differentiated intestinal epithelial cells. Biochem. Biophys. Res. Commun. 2009;378:738–743
  20. Chaigne-Delalande B, Moreau JF, Legembre P. Rewinding the DISC. Arch. Immunol. Ther. Exp. (Warsz). 2008;56:9–14
  21. Cheng A, Tang H, Cai J, Zhu M, Zhang X, Rao M, et al. Gap junctional communication is required to maintain mouse cortical neural progenitor cells in a proliferative state. Dev. Biol. 2004;272:203–216
  22. Chowdhury I, Tharakan B, Bhat GK. Current concepts in apoptosis: the physiological suicide program revisited. Cell. Mol. Biol. Lett. 2006;11:506–525
  23. Cordes N, Meineke V. Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlenther. Onkol. 2003;179:337–344
  24. Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood. 1999;93:1658–1667
  25. Damiano JS, Hazlehurst LA, Dalton WS. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia. 2001;15:1232–1239
  26. Davidson JS, Baumgarten IM, Harley EH. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem. Biophys. Res. Commun. 1986;134:29–36
  27. De Santis G, Miotti S, Mazzi M, Canevari S, Tomassetti A. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene. 2009;28:1206–1217
  28. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell. 2002;111:29–40
  29. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30:256–268
  30. Denys H, Braems G, Lambein K, Pauwels P, Hendrix A, De Boeck A, et al. The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment. Curr. Pharm. Des. 2009;15:1373–1384
  31. Dolberg DS, Bissell MJ. Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature. 1984;309:552–556
  32. Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J. Pathol. 2008;214:283–293
  33. Durand RE, Sutherland RM. Effects of intercellular contact on repair of radiation damage. Exp. Cell Res. 1972;71:75–80
  34. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 1999;68:383–424
  35. Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF. Overcoming apoptosis deficiency of melanoma – hope for new therapeutic approaches. Drug Resist. Updates. 2007;10:218–234
  36. Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, Upadhyay R, et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat. Med. 2008;14:1351–1356
  37. Festjens N, Vanden Berghe T, Vandenabeele P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim. Biophys. Acta. 2006;1757:1371–1387
  38. Fincham VJ, James M, Frame MC, Winder SJ. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 2000;19:2911–2923
  39. Fortney JE, Zhao W, Wenger SL, Gibson LF. Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy. Leukemia Res. 2001;25:901–907
  40. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc. Natl. Acad. Sci. U.S.A. 1990;87:6698–6702
  41. Frisch SM, Francis H. Disruption of epithelial cell–matrix interactions induces apoptosis. J. Cell Biol. 1994;124:619–626
  42. Fung C, Lock R, Gao S, Salas E, Debnath J. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell. 2008;19:797–806
  43. Galante JM, Mortenson MM, Bowles TL, Virudachalam S, Bold RJ. ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis. J. Surg. Res. 2009;152:18–25
  44. Green KJ, Jones JC. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J. 1996;10:871–881
  45. Guan JL. Focal adhesion kinase in integrin signaling. Matrix Biol. 1997;16:195–200
  46. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, et al. Gene promoter methylation in prostate tumor-associated stromal cells. J. Natl. Cancer Inst. 2006;98:255–261
  47. Hazlehurst LA, Argilagos RF, Emmons M, Boulware D, Beam CA, Sullivan DM, et al. Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells. Cancer Res. 2006;66:2338–2345
  48. Hazlehurst LA, Landowski TH, Dalton WS. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncogene. 2003;22:7396–7402
  49. Hazlehurst LA, Valkov N, Wisner L, Storey JA, Boulware D, Sullivan DM, et al. Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood. 2001;98:1897–1903
  50. Heino J, Käpylä J. Cellular receptors of extracellular matrix molecules. Curr. Pharm. Des. 2009;15:1309–1317
  51. Herrenknecht K, Ozawa M, Eckerskorn C, Lottspeich F, Lenter M, Kemler R. The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc. Natl. Acad. Sci. U.S.A. 1991;88:9156–9160
  52. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr. Opin. Genet. Dev. 2008;18:27–34
  53. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genet. 2005;37:899–905
  54. Kao GD, Jiang Z, Fernandes AM, Gupta AK, Maity A. Inhibition of phosphatidyl inositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation. J. Biol. Chem. 2007;282:21206–21212
  55. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond. Cancer Metast. Rev. 2006;25:521–529
  56. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820–827
  57. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 1972;26:239–257
  58. Kim KS. Multifunctional role of Fas-associated death domain protein in apoptosis. J. Biochem. Mol. Biol. 2002;35:1–6
  59. Kinch MS, Petch L, Zhong C, Burridge K. E-cadherin engagement stimulates tyrosine phosphorylation. Cell. Adhes. Commun. 1997;4:425–437
  60. Knudsen KA, Wheelock MJ. Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin. J. Cell Biol. 1992;118:671–679
  61. Konopleva M, Andreeff M. Targeting the leukemia microenvironment. Curr. Drug Targets. 2007;8:685–701
  62. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia. 2002;16:1713–1724
  63. Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L, et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin. Cancer Res. 2003;9:4914–4925
  64. Krysko DV, Leybaert L, Vandenabeele P, D’Herde K. Gap junctions and the propagation of cell survival and cell death signals. Apoptosis. 2005;10:459–469
  65. Kurosaka S, Kashina A. Cell biology of embryonic migration. Birth Defects Res. C Embryo Today. 2008;84:102–122
  66. Lavoie JN, L’Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 1996;271:20608–20616
  67. Layer PG, Robitzi A, Rothermel A, Willbold E. Of layers and spheres: the reaggregate in tissue engineering. Trends Neurosci. 2002;25:131–134
  68. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein. Bim. J. Biol. Chem. 2003;278:18811–18816
  69. Ley R, Ewings KE, Hadfield K, Howes E, Balmanno K, Cook SJ. Extracellular signal-regulated kinases 1/2 are serum-stimulated “Bim(EL) kinases” that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J. Biol. Chem. 2004;279:8837–8847
  70. Liu Z, Li H, Wu X, Yoo BH, Yan SR, Stadnyk AW, et al. Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells. Oncogene. 2006;25:7680–7690
  71. Lobo MV, Alonso FJ, Redondo C, Lopez-Toledano MA, Caso E, Herranz AS, et al. Cellular characterization of epidermal growth factor-expanded free-floating neurospheres. J. Histochem. Cytochem. 2003;51:89–103
  72. Lock R, Debnath J. Extracellular matrix regulation of autophagy. Curr. Opin. Cell Biol. 2008;20:583–588
  73. Lorenzo HK, Susin SA. Therapeutic potential of AIF-mediated caspase-independent programmed cell death. Drug Resist. Updates. 2007;10:235–255
  74. Lwin T, Hazlehurst LA, Li Z, Dessureault S, Sotomayor E, Moscinski LC, et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia. 2007;21:1521–1531
  75. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell. Biol. 2007;8:741–752
  76. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129:1261–1274
  77. Matsunaga T, Fukai F, Miura S, Nakane Y, Owaki T, Kodama H, et al. Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia. Leukemia. 2008;22:353–360
  78. Mawji IA, Simpson CD, Gronda M, Williams MA, Hurren R, Henderson CJ, et al. A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis. Cancer Res. 2007;67:8307–8315
  79. Mawji IA, Simpson CD, Hurren R, Gronda M, Williams MA, Filmus J, et al. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. J. Natl. Cancer Inst. 2007;99:811–822
  80. McCrea PD, Gumbiner BM. Purification of a 92-kDa cytoplasmic protein tightly associated with the cell–cell adhesion molecule E-cadherin (uvomorulin). Characterization and extractability of the protein complex from the cell cytostructure. J. Biol. Chem. 1991;266:4514–4520
  81. Meier P, Vousden KH. Lucifer's labyrinth – ten years of path finding in cell death. Mol. Cell. 2007;28:746–754
  82. Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem. Sci. 2005;30:151–159
  83. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat. Cell Biol. 2002;4:E83–90
  84. Monier-Gavelle F, Duband JL. Cross talk between adhesion molecules: control of N-cadherin activity by intracellular signals elicited by beta1 and beta3 integrins in migrating neural crest cells. J. Cell Biol. 1997;137:1663–1681
  85. Moretti L, Yang ES, Kim KW, Lu B. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist. Updates. 2007;10:135–143
  86. Morin PJ. Drug resistance and the microenvironment: nature and nurture. Drug Resist. Updates. 2003;6:169–172
  87. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 2002;14:381–395
  88. Niedermeier M, Hennessy BT, Knight ZA, Henneberg M, Hu J, Kurtova AV, et al. Isoform-selective phosphoinositide 3’-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach. Blood. 2009;113:5549–5557
  89. Nimmanapalli R, Gerbino E, Dalton WS, Gandhi V, Alsina M. HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma. Br. J. Haematol. 2008;142:551–561
  90. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64:6892–6899
  91. Olive PL, Durand RE, Banath JP, Evans HH. Etoposide sensitivity and topoisomerase II activity in Chinese hamster V79 monolayers and small spheroids. Int. J. Radiat. Biol. 1991;60:453–466
  92. Oliveira R, Christov C, Guillamo JS, de Bouard S, Palfi S, Venance L, et al. Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol. 2005;6:7
  93. Opel D, Westhoff MA, Bender A, Braun V, Debatin KM, Fulda S. Phosphatidylinositol 3-kinase inhibition sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res. 2008;68:6271–6280
  94. Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell. Biol. 2008;9:532–542
  95. Paget S. The distribution of secondary growths in cancer of the breast, 1889. Cancer Metast. Rev. 1989;8:98–101
  96. Peyssonnaux C, Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell. 2001;93:53–62
  97. Prochnow N, Dermietzel R. Connexons and cell adhesion: a romantic phase. Histochem. Cell. Biol. 2008;130:71–77
  98. Puck TT, Marcus PI, Cieciura SJ. Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer. J. Exp. Med. 1956;103:273–283
  99. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int. J. Biochem. Cell Biol. 2008;40:2707–2719
  100. Ray RM, Vaidya RJ, Johnson LR. MEK/ERK regulates adherens junctions and migration through Rac1. Cell. Motil. Cytoskeleton. 2007;64:143–156
  101. Rivard N. Phosphatidylinositol 3-kinase: a key regulator in adherens junction formation and function. Front. Biosci. 2009;14:510–522
  102. Ruhul Amin AR, Senga T, Oo ML, Thant AA, Hamaguchi M. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk. Genes Cell. 2003;8:515–523
  103. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 2005;353:811–822
  104. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 1994;372:786–791
  105. Schmidmaier R, Oellerich M, Baumgart J, Emmerich B, Meinhardt G. Treosulfan-induced apoptosis in acute myeloid leukemia cells is accompanied by translocation of protein kinase C delta and enhanced by bryostatin-1. Exp. Hematol. 2004;32:76–86
  106. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 1999;5:662–668
  107. Shain KH, Landowski TH, Dalton WS. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines. J. Immunol. 2002;168:2544–2553
  108. Shain KH, Yarde DN, Meads MB, Huang M, Jove R, Hazlehurst LA, et al. Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation. Cancer Res. 2009;69:1009–1015
  109. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G, et al. Structural basis of cell–cell adhesion by cadherins. Nature. 1995;374:327–337
  110. Shen X, Kramer RH. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am. J. Pathol. 2004;165:1315–1329
  111. Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272:177–185
  112. Smolle J, Hofmann-Wellenhof R, Fink-Puches R. Melanoma and stroma: an interaction of biological and prognostic importance. Semin. Cutan. Med. Surg. 1996;15:326–335
  113. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 2001;155:459–470
  114. Sutherland RM, Durand RE. Cell contact as a possible contribution to radiation resistance of some tumours. Br. J. Radiol. 1972;45:788–789
  115. Taneyhill LA. To adhere or not to adhere: the role of cadherins in neural crest development. Cell Adhes. Migr. 2008;2:223–230
  116. Taylor ST, Hickman JA, Dive C. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J. Natl. Cancer Inst. 2000;92:18–23
  117. Tsukita S, Yamazaki Y, Katsuno T, Tamura A. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene. 2008;27:6930–6938
  118. Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin. Cancer Res. 1999;5:1587–1594
  119. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 2004;14:198–206
  120. Wang X, Wang C, Qin YW, Yan SK, Gao YR. The association of up-regulation of X-linked inhibitor of apoptosis protein with cell adhesion-mediated drug resistance in U937 cells. Hematol. Oncol. 2008;26:21–26
  121. Wang Y, Yang H, Liu H, Huang J, Song X. Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro study. BMC Cancer. 2009;9:174
  122. Wei Y, Fan T, Yu M. Inhibitor of apoptosis proteins and apoptosis. Acta Biochim. Biophys. Sin. (Shanghai). 2008;40:278–288
  123. Westhoff MA, Kandenwein JA, Karl S, Vellanki SHK, Braun V, Eramo A, et al. The pyridinylfuranopyrimidine inhibitor PI-103 chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair. Oncogene. 2009;[Epub]
  124. Westhoff MA, Zhou S, Bachem MG, Debatin KM, Fulda S. Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells. Oncogene. 2008;27:5169–5181
  125. Weston CR, Balmanno K, Chalmers C, Hadfield K, Molton SA, Ley R, et al. Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. Oncogene. 2003;22:1281–1293
  126. Woods NT, Yamaguchi H, Lee FY, Bhalla KN, Wang HG. Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Res. 2007;67:10744–10752
  127. Xu Y, Guo DF, Davidson M, Inagami T, Carpenter G. Interaction of the adaptor protein Shc and the adhesion molecule cadherin. J. Biol. Chem. 1997;272:13463–13466
  128. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin–catenin–actin complex. Cell. 2005;123:889–901
  129. Yan L, Lavin VA, Moser LR, Cui Q, Kanies C, Yang E. PP2A regulates the pro-apoptotic activity of FOXO1. J. Biol. Chem. 2008;283:7411–7420
  130. Yan SR, Joseph RR, Rosen K, Reginato MJ, Jackson A, Allaire N, et al. Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells. Oncogene. 2005;24:6482–6491

PII: S1368-7646(09)00049-1

doi: 10.1016/j.drup.2009.08.001

Drug Resistance Updates
Volume 12, Issue 4 , Pages 127-136 , August 2009

Article Tools

* Image Usage & Resolution